CULLINAN THERAPEUTICS, INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 27.76 USD | -5.43% |
|
-0.96% | +173.11% |
| 04-29 | Cullinan Therapeutics Appoints Mary Kay Fenton as CFO | MT |
| 04-29 | Cullinan Therapeutics, Inc Appoints Mary Kay Fenton as Chief Financial Officer | CI |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Bullish | Bullish |
| Resistance | 35.91 | 45.73 | 33.11 |
| Spread/Res. | -22.50% | -39.14% | -15.95% |
| Spread/Supp. | +31.77% | +78.06% | +77.71% |
| Support | 21.12 | 15.63 | 15.66 |
Technical Rankings Surperformance
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- CGEM Stock
- Charts Cullinan Therapeutics, Inc.